Overcoming the genotoxicity of a pyrrolidine substituted arylindenopyrimidine as a potent dual adenosine A(2A)/A(1) antagonist by minimizing bioactivation to an iminium ion reactive intermediate.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Chemical Research in Toxicology

• Publication date

  2011-06-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/tx1004437PMID 21667953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylene amine substituted arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists.

  2010cited by this paper
• The development and use of iridium(I) phosphine systems for ortho‐directed hydrogen‐isotope exchange

  2010cited by this paper
• Inhibitory properties of trapping agents: glutathione, potassium cyanide, and methoxylamine, against major human cytochrome p450 isoforms.

  2009cited by this paper
• Toxicophores, reactive metabolites and drug safety: when is it a cause for concern?

  2008cited by this paper
• Minimizing metabolic activation during pharmaceutical lead optimization: progress, knowledge gaps and future directions.

  2008cited by this paper
• 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) Revisited: Comparative Cytochrome P450 Inhibition in Human Liver Microsomes by SKF525A, Its Metabolites, and SKF-Acid and SKF-Alcohol

  2008cited by this paper
• A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry.

  2008cited by this paper
• Novel approach to performing metabolite identification in drug metabolism.

  2007cited by this paper
• Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation

  2007cited by this paper
• Analysis of crotonaldehyde- and acetaldehyde-derived 1,n(2)-propanodeoxyguanosine adducts in DNA from human tissues using liquid chromatography electrospray ionization tandem mass spectrometry.

  2006cited by this paper
• Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

  2005cited by this paper
• Covalent modifications to 2'-deoxyguanosine by 4-oxo-2-nonenal, a novel product of lipid peroxidation.

  1999cited by this paper
• Mechanism for the catalytic activation of ecteinascidin 743 and its subsequent alkylation of guanine N2

  1998cited by this paper
• The metabolism of alicyclic amines to reactive iminium ion intermediates

  1994cited by this paper
• Application of chemical cytochrome P-450 model systems to studies on drug metabolism. IV. Mechanism of piperidine metabolism pathways via an iminium intermediate.

  1991cited by this paper
• Quantitative predictability of carcinogenicity of the covalent binding index of chemicals to DNA: comparison of the in vivo and in vitro assays.

  1990cited by this paper
• Regio- and stereochemical studies on the alpha-carbon oxidation of (S)-nicotine by cytochrome P-450 model systems.

  1988cited by this paper
• Metabolic studies on phencyclidine: characterization of a phencyclidine iminium ion metabolite.

  1988cited by this paper
• Metabolism-dependent covalent binding of (S)-[5-3H]nicotine to liver and lung microsomal macromolecules.

  1988cited by this paper
• Characterization of glutathione conjugates by fast atom bombardment/tandem mass spectrometry.

  1988cited by this paper
• Pyrrolo(l ,4)benzodiazepine Antitumor Antibiotics: Chemistry, Interaction with DNA, and Biological Implications

  1984cited by this paper
• RING-CHAIN TAUTOMERISM OF PSEUDOOXYNICOTINE AND SOME OTHER IMINIUM COMPOUNDS

  1984cited by this paper
• Revised methods for the Salmonella mutagenicity test.

  1983cited by this paper
• Frameshift mutations: relative roles of simple intercalation and of adduct formation.

  1981cited by this paper
• The tautomeric structures of 5-hydroxycotinine, a secondary mammalian metabolite of nicotine

  1981cited by this paper
• Trapping of metabolically generated electrophilic species with cyanide ion: metabolism of 1-benzylpyrrolidine.

  1980cited by this paper
• Acridine structure correlated with mutagenic activity in Salmonella.

  1980cited by this paper
• Handbook of Analytical Derivatization Reactions

  1980cited by this paper
• DNA--benzo[a]pyrene adducts formed in a Salmonella typhimurium mutagenesis assay system.

  1979cited by this paper
• Inhibition by cyanide of drug oxidations in rat liver microsomes.

  1977cited by this paper
• Enzymatic oxidation of nicotine to nicotine 1'(5') iminium ion. A newly discovered intermediate in the metabolism of nicotine.

  1973cited by this paper
• An improved bacterial test system for the detection and classification of mutagens and carcinogens.

  1973cited by this paper
• HEPATIC ALDEHYDE OXIDASE. II. DIFFERENTIAL INHIBITION OF ELECTRON TRANSFER TO VARIOUS ELECTRON ACCEPTORS.

  1964cited by this paper
• β-Condensation Reactions of Cyclic Amines with Benzaldehyde: Evidence for the Enamine Pathway

  1963cited by this paper

• Mitigating a Bioactivation Liability with an Azetidine-Based Inhibitor of Diacylglycerol Acyltransferase 2 (DGAT2) En Route to the Discovery of the Clinical Candidate Ervogastat.

  2023cites this paper
• Metabolism and disposition of JNJ-10450232 (NTM-006) in rats, dogs, nonhuman primates and humans.

  2023cites this paper
• Indane-1,3-Dione: From Synthetic Strategies to Applications

  2022cites this paper
• Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson's Disease.

  2021cites this paper
• Disposition and metabolism of 2,2′-dimorpholinodiethyl ether in sprague dawley rats and B6C3F1/N mice after oral, intravenous administration, and dermal application

  2020cites this paper
• Is There Enough Evidence to Classify Cycloalkyl Amine Substituents as Structural Alerts?

  2020cites this paper
• Designing Around Structural Alerts in Drug Discovery.

  2020cites this paper
• Formation and repair of unavoidable, endogenous interstrand cross-links in cellular DNA.

  2020cites this paper
• Ag2O on ZrO2 as a Recyclable Catalyst for Multicomponent Synthesis of Indenopyrimidine Derivatives

  2018cites this paper
• Systematic Approach to Organizing Structural Alerts for Reactive Metabolite Formation from Potential Drugs.

  2018cites this paper
• Insights about the toxic effects of tannery effluent on Lithobates catesbeianus tadpoles.

  2018cites this paper
• Safety issues of compounds acting on adenosinergic signalling

  2017cites this paper
• Liabilities Associated with the Formation of "Hard" Electrophiles in Reactive Metabolite Trapping Screens.

  2017cites this paper
• Detecting reactive drug metabolites for reducing the potential for drug toxicity

  2015cites this paper
• Synthesis of a series of novel 2- aminopyrimidine derivatives and their biological evaluation as adenosine receptor antagonists

  2015cites this paper
• 2-Aminopyrimidines as dual adenosine A1/A2A antagonists.

  2015cites this paper
• Adenosine A 2A Receptor Antagonists

  2014cites this paper
• Metabolism and Excretion of Canagliflozin in Mice, Rats, Dogs, and Humans

  2014cites this paper
• Metabolism and Excretion of Canagliflozin in Mice, Rats, Dogs, and Humans s

  2014cites this paper
• JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.

  2014cites this paper
• A Nonradioactive Approach to Investigate the Metabolism of Therapeutic Peptides by Tagging with 127I and Using Inductively-Coupled Plasma Mass Spectrometry Analysis

  2014cites this paper
• Trouble-Free Multicomponent Method for Combinatorial Synthesis of 2‑Amino-4-phenyl-5‑H‑indeno[1,2‑d]pyrimidine-5-one and Their Screening against Cancer Cell Lines

  2014cites this paper
• Adenosine A1 modulators: a patent update (2008 to present)

  2013cites this paper
• Bioactivation of the cannabinoid receptor antagonist rimonabant to a cytotoxic iminium ion metabolite.

  2013cites this paper
• Selected scientific topics of the 11th International Isotope Symposium on the Synthesis and Applications of Isotopes and Isotopically Labeled Compounds.

  2013cites this paper
• Metabolism-guided drug design

  2013cites this paper
• Structural optimization of quinolon-4(1H)-imines as dual-stage antimalarials: toward increased potency and metabolic stability.

  2013cites this paper
• In vitro bioactivation of a selective estrogen receptor modulator (2S,3R)-(+)-3-(3-hydroxyphenyl)-2-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol (I) in liver microsomes: formation of adenine adducts.

  2012cites this paper
• Covalent Drug–Protein Adducts: An Exploration of Their Role in Drug‐Induced Liver and General Organ Toxicity

  2012cites this paper
• Role of Reactive Metabolites in Genotoxicity

  2012cites this paper
• Metabolic Stability and Analogue‐Based Drug Discovery

  2012cites this paper
• Design and characterization of optimized adenosine A₂A/A₁ receptor antagonists for the treatment of Parkinson's disease.

  2012cites this paper
• Simultaneous Screening of Glutathione and Cyanide Adducts Using Precursor Ion and Neutral Loss Scans-Dependent Product Ion Spectral Acquisition and Data Mining Tools

  2012cites this paper
• Structural Alerts for Toxicity

  2010cites this paper